TagCyx is a research based company based in Tokyo (Japan), founded in March 2007 as a spin out company of RIKEN.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Tokyo
State: Tokyo
Zip:
Country: Japan
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Venture Round | 3 | $1.9M |
Healthcare Innovation SBI Group UTokyo Innovation Platform Healthcare Innovation SBI Group UTokyo Innovation Platform |
4/2018 | Series B | 4 | $4.6M |
Mizuho Capital SMBC Venture Capital UTEC - The University of Tokyo Edge Capital Partners UTokyo Innovation Platform Mizuho Capital SMBC Venture Capital UTEC - The University of Tokyo Edge Capital Partners UTokyo Innovation Platform |
4/2020 | Venture Round | 1 | $1.9M |
UTokyo Innovation Platform UTokyo Innovation Platform |
8/2016 | Venture Round | 3 | $4.8M |
Nissay Capital SMBC Venture Capital UTEC - The University of Tokyo Edge Capital Partners Nissay Capital SMBC Venture Capital UTEC - The University of Tokyo Edge Capital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|